UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000019985
Receipt No. R000023017
Scientific Title Effect of botulinum toxin on Raynaud's phenomenon in patients with systemic sclerosis
Date of disclosure of the study information 2015/12/16
Last modified on 2016/09/23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of botulinum toxin on Raynaud's phenomenon in patients with systemic sclerosis
Acronym BTX on Raynaud's phenomenon in SSc
Scientific Title Effect of botulinum toxin on Raynaud's phenomenon in patients with systemic sclerosis
Scientific Title:Acronym BTX on Raynaud's phenomenon in SSc
Region
Japan

Condition
Condition Raynaud's phenomenon
Classification by specialty
Clinical immunology Dermatology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess the efficacy and safety of BTX on Raynaud's pehnomenon in Japanese patients with SSc.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The change in severity of RP, including the frequency, pain, color and duration, by the Raynaud score and VAS at 4 weeks after treatment compared with the baseline.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 4
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 No treatment
Interventions/Control_2 Low dose of botulinum toxin injection
Interventions/Control_3 Medium dose of botulinum toxin injection
Interventions/Control_4 High dose of botulinum toxin injection
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria All patients fulfilled the criteria of SSc proposed by the American College of Rheumatology and the American College of Rheumatology/European League Against Rheumatism classification criteria.
Key exclusion criteria Patients under the age 18, with the pregnancy or having the past medical histories with BTX were excluded.
Target sample size 40

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Sei-ichiro Motegi
Organization Gunma University Graduate School of Medicine
Division name Department of Dermatology
Zip code
Address 3-39-22 Showa, Maebashi, Gunma 371-8511.
TEL 027-220-8284
Email smotegi@gunma-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Sei-ichiro Motegi
Organization Gunma University Graduate School of Medicine
Division name Department of Dermatology
Zip code
Address 3-39-22 Showa, Maebashi, Gunma 371-8511.
TEL 027-220-8284
Homepage URL
Email smotegi@gunma-u.ac.jp

Sponsor
Institute Gunma University Hospital
Institute
Department

Funding Source
Organization Japanese Ministry of Health, Labour
and Welfare
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 16 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 10 Month 29 Day
Date of IRB
Anticipated trial start date
2015 Year 12 Month 16 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2015 Year 11 Month 29 Day
Last modified on
2016 Year 09 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023017

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.